Elevated prostate specific antigen [PSA]
Specimen Required
This screening procedure code requires a diagnosis code of V76.44 that must appear on the claim form. If the patient has symptoms of prostate carcinoma along with the BPH, such as hematuria, nocturia, urinary frequency, and slow stream, a diagnostic PSA can be covered.
. Medicare coverage for screening PSAs is limited to once every 12 months Diagnostic PSAs CPT codes for diagnostic PSA tests are 84153: EPIC: LAB4427 TIP: Free and Total PSA is a diagnostic PSA and should be coded as such.
R97. 20 - Elevated prostate specific antigen [PSA]. ICD-10-CM.
*October 2017 Changes. ICD-10-CM Version – Red. ... Fu Associates, Ltd. ... 190.31 - Prostate Specific Antigen. ... Total PSA. ... Prostate Specific Antigen (PSA), a tumor marker for adenocarcinoma of the prostate, can predict residual tumor in the post-operative phase of prostate cancer. ... © ... Code. ... ICD-10-CM Codes Covered by Medicare Program.More items...
Elevated prostate-specific antigen (PSA) levels can be a sign of prostate cancer. It can also indicate noncancerous problems such as prostate enlargement and inflammation.
Some payers, including Medicare, have different coding requirements for screening and diagnostic PSA tests. For a Medicare patient, report a screening PSA with G0103 Prostate cancer screening; prostate specific antigen test (PSA) and a diagnostic PSA with one of the following three codes (based on the type of test): ...
For a screening test for a patient with no signs or symptoms of disease, use diagnosis code Z12.5 Encounter for screening for malignant neoplasm of prostate. If you report another diagnosis code with G0103, Medicare will not pay for it. You must use a screening diagnosis with a screening CPT® code.
Or if the urologist only notes signs and symptoms, codes such as R39.11 Hesitancy of micturition may apply. Medicare will consider many diagnosis codes indicating urological signs or symptoms as payable for PSA determinations, such as: This, of course, is a short list.
Prostate specific antigen (PSA) screenings are commonplace in most urology practices, which means if you don’t have your procedure and diagnosis coding straight, you may face high denial rates and possibly significant revenue loss. Avoid those pitfalls with these three tips.
Once you decide on the codes , there’s one more point to check before submitting the claim: Payers have tight restrictions on the frequency for which they will pay for PSA tests.
You should not need modifier 25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service on the E/M service, as a global period does not apply to the PSA laboratory test.
If the urologist performs a separate evaluation and management (E/M) service during the same encounter as the PSA test, you should be able to separately report the PSA test code and the appropriate E/M code (based on the documented level of service).
Elevated prostate specific antigen [PSA] 1 R97.20 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM R97.20 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R97.20 - other international versions of ICD-10 R97.20 may differ.
R97.20 is not usually sufficient justification for admission to an acute care hospital when used a principal diagnosis. The following code (s) above R97.20 contain annotation back-references. Annotation Back-References.